FORTREA HOLDINGS INC. Operating Cash Flow
FORTREA HOLDINGS INC. (FTRE) reported Operating Cash Flow of $11.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-29
- FORTREA HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $28.90M, a 32.57% increase year-over-year.
- FORTREA HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$17.00M.
- FORTREA HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $129.10M, a 654.97% increase year-over-year.
- FORTREA HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $86.80M.
- FORTREA HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2025 was $113.50M, a 56.81% decline from fiscal 2024.
- FORTREA HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2024 was $262.80M, a 56.06% increase from fiscal 2023.
- FORTREA HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2023 was $168.40M, a 103.63% increase from fiscal 2022.
- FORTREA HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2022 was $82.70M, a 51.30% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $28.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $11.90M 10-Q · filed 2026-07-29 | $141.00M derived: sum of 3 quarters · filed 2026-07-29 | $227.80M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2026-03-31 | -$17.00M 10-Q · filed 2026-05-05 | $112.10M derived: sum of 2 quarters · filed 2026-05-05 | $198.90M derived: sum of 3 quarters · filed 2026-05-05 | $220.70M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-12-31 | $129.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $215.90M derived: sum of 2 quarters · filed 2026-02-26 | $237.70M derived: sum of 3 quarters · filed 2026-07-29 | $113.50M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $86.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $108.60M derived: sum of 2 quarters · filed 2026-07-29 | -$15.60M 10-Q · filed 2025-11-05 | $1.50M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-06-30 | $21.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$102.40M 10-Q · filed 2026-07-29 | -$85.30M derived: sum of 3 quarters · filed 2026-07-29 | -$87.70M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-03-31 | -$124.20M 10-Q · filed 2026-05-05 | -$107.10M derived: sum of 2 quarters · filed 2026-05-05 | -$109.50M derived: sum of 3 quarters · filed 2026-05-05 | $164.20M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.70M derived: sum of 2 quarters · filed 2026-02-26 | $288.40M derived: sum of 3 quarters · filed 2026-02-26 | $262.80M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $271.30M derived: sum of 2 quarters · filed 2025-11-05 | $245.70M 10-Q · filed 2025-11-05 | $264.10M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $273.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $248.10M 10-Q · filed 2025-08-06 | $266.50M derived: sum of 3 quarters · filed 2026-02-26 | $268.40M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$25.60M 10-Q · filed 2025-05-12 | -$7.20M derived: sum of 2 quarters · filed 2026-02-26 | -$5.30M derived: sum of 3 quarters · filed 2026-02-26 | $144.80M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $18.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.30M derived: sum of 2 quarters · filed 2026-02-26 | $170.40M derived: sum of 3 quarters · filed 2026-02-26 | $168.40M 10-K · filed 2026-02-26 | $167.40M 10-K · filed 2024-03-13 | ||
| 2023-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $152.00M derived: sum of 2 quarters · filed 2024-11-08 | $150.00M 10-Q · filed 2024-11-08 | $155.00M 10-Q · filed 2023-11-13 | $173.50M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $150.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $148.10M 10-Q · filed 2024-08-12 | $154.20M 10-Q · filed 2023-08-14 | $171.60M derived: sum of 3 quarters · filed 2025-03-03 | $252.50M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | -$2.00M 10-Q · filed 2024-05-24 | $21.50M derived: sum of 2 quarters · filed 2025-03-03 | $102.40M derived: sum of 3 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $23.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $104.40M derived: sum of 2 quarters · filed 2025-03-03 | $82.70M 10-K · filed 2025-03-03 | $87.50M 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $80.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $59.20M 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | -$21.70M 10-Q · filed 2023-08-14 | ||||||
| 2021-12-31 | $169.80M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |